Target intelligence / Profile preview

DDRGK domain-containing protein 1 (DDRGK1)

Target
DDRGK1
Molecular classification
UFM1 system component, UFM1-binding protein, PCI domain-containing protein, Other
01

Overview

DDRGK domain-containing protein 1 (**DDRGK1**) is a key component of the UFM1 conjugation (ufmylation) system, acting both as a scaffold and a reader for UFM1-modified proteins at the endoplasmic reticulum (ER)[3]. Its PCI domain mediates protein interactions, while an N-terminal signal peptide anchors it to the ER membrane[1][2][3]. DDRGK1 regulates lysosomal function and autophagy, controls the unfolded protein response, and is essential for the proper recycling of ribosomes from the ER. It further modulates NF-κB signaling and affects apoptosis in ER-stressed secretory tissues[3][4]. Loss or dysfunction of DDRGK1 has been implicated in hematopoietic disorders, impaired plasma cell differentiation, specific genetic dysplasias, and intestinal inflammation. Direct pharmacological targeting of DDRGK1 is not established, but its central role in cellular stress responses and immunity highlights its potential as a future therapeutic target.

Other names
C20orf116UFBP1DashurindJ1187M17.3UFM1-binding and PCI domain-containing protein 1SEMDSH
02

Biological functions

Regulation of autophagy and lysosomal functionMaintenance of endoplasmic reticulum homeostasisRegulation of apoptosisRegulation of ER stress response and unfolded protein response (UPR)NF-κB signaling regulationRegulation of ribosome recycling and ufmylationRegulation of plasma cell differentiation and immune functionCartilage development via SOX9 stabilization
03

Disease associations

Hematopoietic dysfunctionPlasma cell differentiation defectsIntestinal inflammationSpondyloepimetaphyseal dysplasia, Shohat type ("SEMDSH")ER stress-associated secretory tissue apoptosis
04

Safety considerations

Loss of DDRGK1 leads to extensive ER stress and increased apoptosis, potentially compromising cellular viability

Beyond the preview

Go deeper on DDRGK domain-containing protein 1 (DDRGK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DDRGK domain-containing protein 1 (DDRGK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call